Shanghai Gentech (688596.SH) has received approval for the issuance of convertible bonds from the Shanghai Stock Exchange Listing Review Committee.

Shanghai Gentech (688596.SH) announced that the Shanghai Stock Exchange Listing Committee held its first review meeting of 2025 on January 10, 2025 (referred to as the "meeting"), where they reviewed the company's application to issue convertible corporate bonds to unspecified investors. According to the review results of the meeting, the company's application to issue convertible corporate bonds to unspecified investors meets the issuance conditions, listing conditions, and disclosure requirements. The issuance of convertible corporate bonds to unspecified investors by the company is subject to approval from the China Securities Regulatory Commission before it can be implemented. There is still uncertainty regarding whether this issuance will ultimately be approved by the China Securities Regulatory Commission and the timeline for their decision.